FDA Adverse Event Injury Summary report: N

HOMECHOICE LOW RECIRCULATION VOLUME APD SET WITH CASSETTE

MDR report key: 3031589 · Received April 2, 2013

Report

Report Number
1416980-2013-08169
Event Type
Injury
Date Received
April 2, 2013
Date of Event
March 11, 2013
Report Date
March 12, 2013
Manufacturer
BAXTER HEALTHCARE - MOUNTAIN HOME
Product Code
FKX
PMA / PMN Number
K012988
Adverse Event
Yes
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
CA, US
Reporter Occupation
NURSE

Narratives

Additional Manufacturer Narrative · 1

(B)(4). A REVIEW OF ALL BATCH RECORD DOCUMENTS WAS PERFORMED WITH NO ISSUES NOTED DURING THE MANUFACTURING PROCESS. THERE WERE NO DEVIATIONS FROM STANDARD PROCEDURE AND NO EXCEPTIONS RELATED TO THE REPORTED CONDITION WERE NOTED. THE DEVICE HAS BEEN RECEIVED FOR EVALUATION. UPON COMPLETION OF THE EVALUATION OR SHOULD ANY ADDITIONAL RELEVANT INFORMATION BECOME AVAILABLE, A FOLLOW UP MDR WILL BE SENT.

Additional Manufacturer Narrative · 1

(B)(4). THE ACTUAL SAMPLE WAS RETURNED AND EVALUATED. THE REPORTED ISSUE OF A LEAK WAS CONFIRMED FROM THE SAMPLE EVALUATION AS A HOLE WAS FOUND IN THE PATIENT LINE, THE CAUSE OF THE HOLE WAS NOT DETERMINED.

Description of Event or Problem · 1

THIS IS A REPORT OF A HOME PATIENT (HP) WHO HAD THEIR DISPOSABLE CASSETTE LEAK DURING PERITONEAL DIALYSIS (PD) THERAPY AND WAS SUBSEQUENTLY DIAGNOSED WITH PERITONITIS. IT WAS REPORTED THAT A LEAK WAS FOUND COMING FROM A PINHOLE IN THE CASSETTE'S PATIENT LINE. THE HP WAS HOSPITALIZED AS A PRECAUTIONARY MEASURE FOR THE LEAKING CASSETTE AND WAS DIAGNOSED WITH PERITONITIS DURING HOSPITALIZATION. THE HP WAS TREATED WITH VANCOMYCIN, 1G, INTRA-PERITONEALLY, WITH EACH THERAPY FOR 15 DAYS. PD THERAPY WAS ONGOING. THE HP WAS CONSIDERED TO BE RECOVERING FROM THE PERITONITIS.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
134956 HOMECHOICE LOW RECIRCULATION VOLUME APD SET WITH CASSETTE SYSTEM, PERITONEAL, AUTOMATIC DELIVERY FKX BAXTER HEALTHCARE - MOUNTAIN HOME H12A03115

Patients

Seq Age Sex Outcome Treatment
1 9 YR Required Intervention DIANEAL 1.5%, 2.5%, 4.25% AND HOMECHOICE